How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores
Cancers · 16.08.2023 · 15 (16) · 4130
DOI: 10.3390/cancers15164130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.08.2023. Verfasst von Andrea Bianconi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery, Department of Neurosciences, University of Turin, 10126 Turin, Italy. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fluorescence-guided surgery has been increasingly used to support glioma surgery with the purpose of obtaining a maximal safe resection, in particular in high-grade gliomas, while its role is less definitely assessed in low-grade gliomas.
Methods
A systematic review was conducted. 5-aminolevulinic acid, sodium fluorescein, indocyanine green and tozuleristide were taken into account. The main considered outcome was the fluorescence rate, defined as the number of patients in whom positive fluorescence was detected out of the total number of patients. Only low-grade gliomas were considered, and data were grouped according to single fluorophores.
Results
16 papers about 5-aminolevulinic acid, 4 about sodium fluorescein, 2 about indocyanine green and 1 about tozuleristide were included in the systematic review. Regarding 5-aminolevulinic acid, a total of 467 low-grade glioma patients were included, and fluorescence positivity was detected in 34 out of 451 Grade II tumors (7.3%); while in Grade I tumors, fluorescence positivity was detected in 9 out of 16 cases. In 16 sodium fluorescein patients, seven positive fluorescent cases were detected. As far as indocyanine is concerned, two studies accounting for six patients (three positive) were included, while for tozuleristide, a single clinical trial with eight patients (two positive) was retrieved.
Conclusions
The current evidence does not support the routine use of 5-aminolevulinic acid or sodium fluorescein with a standard operating microscope because of the low fluorescence rates. New molecules, including tozuleristide, and new techniques for fluorescence detection have shown promising results; however, their use still needs to be clinically validated on a large scale.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurosurgery, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
- Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
- Humanitas Gradenigo, 10100 Turin, Italy.
ORCID-Profile: Andrea Bianconi, Pietro Zeppa, Fulvio Tartara, Diego Garbossa
Zitieren
APA
Bianconi, A., Bonada, M., Zeppa, P., Colonna, S., Tartara, F., Melcarne, A., Garbossa, D., & Cofano, F. (2023). How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores. Cancers, 15(16), 4130. https://doi.org/10.3390/cancers15164130
Vancouver
Bianconi A, Bonada M, Zeppa P, Colonna S, Tartara F, Melcarne A, et al. How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores. Cancers. 2023;15(16):4130. doi:10.3390/cancers15164130
BibTeX
@article{Bianconi2023,
author = {Bianconi, Andrea and Bonada, Marta and Zeppa, Pietro and Colonna, Stefano and Tartara, Fulvio and Melcarne, Antonio and Garbossa, Diego and Cofano, Fabio},
title = {How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores},
journal = {Cancers},
year = {2023},
volume = {15},
number = {16},
pages = {4130},
doi = {10.3390/cancers15164130}
}
EUVIMED